Category Archives: Regional News

You are here: Home » Category: "Regional News"

Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., April 28, 2017 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the quarter ended March 31, 2017 and provided an update on recent corporate developments. The company will host…

[Read More]

Novan Presents Safety Data for SB204 Program

MORRISVILLE, N.C., April 27, 2017 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that pharmacokinetic data for SB204, a once-daily, topical monotherapy for the treatment of acne vulgaris, will be presented at the 76th Annual Meeting of the Society for Investigative Dermatology in Portland, Oregon. In three pharmacokinetic clinical trials conducted…

[Read More]

Novan Presents Preclinical Data from Inflammatory Skin Diseases Program

MORRISVILLE, N.C., April 27, 2017 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that data from two preclinical studies with SB414, a nitric oxide-releasing cream in development for the treatment of inflammatory skin diseases such as psoriasis and atopic dermatitis, will be presented at the 76th Annual Meeting of the Society…

[Read More]

MacroGenics Announces Registered Direct Offering of Common Stock

Rockville, MD, April 27, 2017 (GLOBE NEWSWIRE) — —  MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases, today announced that it has entered into a definitive agreement with an institutional healthcare investor to…

[Read More]

Onconova Therapeutics Announces Closing of Public Offering of Common Stock

NEWTOWN, Pa., April 26, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS), today announced the closing of its previously announced public offering of 2,476,190 shares of its common stock…

[Read More]

Supernus to Host First Quarter 2017 Earnings Conference Call

ROCKVILLE, Md., April 26, 2017 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report the financial results for the first quarter of 2017 after 5:00 PM ET on Tuesday, May…

[Read More]

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Deutsche Bank 42nd Annual Health Care Conference

ROCKVILLE, Md., April 26, 2017 (GLOBE NEWSWIRE) — Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Deutsche Bank 42nd Annual Health Care Conference on Thursday, May 4th at 12:30 PM ET. Investors interested in arranging a meeting with the Company’s management during this…

[Read More]

OpGen Announces 2017 First Quarter Financial Results

GAITHERSBURG, Md., April 26, 2017 (GLOBE NEWSWIRE) — OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the first quarter ended March 31, 2017 and summarized recent business highlights. “In the first quarter, we presented preliminary results supporting the Acuitas® Rapid Test in development for detection of resistance genes in multi-drug resistant pathogens and…

[Read More]